Georg- August

Aug 26, 2024 | academic.oup.com | von Haehling |Charité- Universitätsmedizin Berlin |Charité Universitätsmedizin Berlin |Georg- August

See the editorial comment for this article ‘Intravenous iron therapy in heart failure with preserved ejection fraction: how far have we walked?’, by V. Kittipibul and R.J. Mentz, https://doi.org/10.1093/eurheartj/ehae490. In chronic heart failure (HF), iron deficiency (ID) is prevalent in up to 50% of all patients.1–3 As a very frequent comorbidity in HF, ID has garnered significant research attention in recent years.